Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28022765 | 0.96 | FFAR1 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL28023419 | 0.96 | FFAR1 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL9379674 | 0.96 | FFAR1 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL28022714 | 0.93 | ACE2 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL28023364 | 0.93 | ACE2 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL28852949 | 0.93 | ACE2 (0.49) | FFAR1FFAR4ACE2GPR84CES2 | |
| SCHEMBL30448065 | 0.93 | LTA4H (0.48) | FFAR1FFAR4ACE2GPR84LTA4H | |
| SCHEMBL30010163 | 0.93 | LTA4H (0.48) | FFAR1FFAR4ACE2GPR84LTA4H | |
| SCHEMBL28445541 | 0.93 | LTA4H (0.48) | FFAR1FFAR4ACE2GPR84LTA4H | |
| SCHEMBL28184413 | 0.89 | ACE2 (0.43) | FFAR1FFAR4ACE2GPR84LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106590908-B | Steam rust-proof fully-synthetic ferrous metal grinding fluid | 清华大学天津高端装备研究院 | 2020-02-21 | — | — | CN | disclosed |
| US-20120088705-A1 | POLYALKYLENE GLYCOL-BASED ETHER PYRROLIDONE CARBOXYLIC ACIDS, AND CONCENTRATES FOR THE PRODUCTION OF SYNTHETIC COOLING LUBRICANTS CONTAINING THE SAME | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088705-A1 | POLYALKYLENE GLYCOL-BASED ETHER PYRROLIDONE CARBOXYLIC ACIDS, AND CONCENTRATES FOR THE PRODUCTION OF SYNTHETIC COOLING LUBRICANTS CONTAINING THE SAME | F12, ADH1A, ADH1C | FFAR1 712/4885FFAR4 2163/4885ACE2 3458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.